CAP

Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resmetirom) Presented at the EASL Congress

Retrieved on: 
Thursday, June 6, 2024

Rezdiffra is a once-daily, oral, liver-directed thyroid hormone receptor (THR)-β agonist designed to target key underlying causes of NASH.

Key Points: 
  • Rezdiffra is a once-daily, oral, liver-directed thyroid hormone receptor (THR)-β agonist designed to target key underlying causes of NASH.
  • Continued approval for this indication may be contingent upon verification and description of clinical benefit in ongoing confirmatory trials.
  • Bill Sibold, Chief Executive Officer of Madrigal, stated, “The ten abstracts Madrigal will be presenting at the EASL Congress further advance our leadership position in NASH.
  • CAP and MRI-PDFF improvements in patients treated with Rezdiffra predicted achieving both fibrosis improvement and NASH resolution responses on histology.

Avistone Announces Results from Two Sponsored Clinical Research Programs at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Retrieved on: 
Tuesday, June 4, 2024

Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision oncology therapeutics, announced results from the two presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL.

Key Points: 
  • Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision oncology therapeutics, announced results from the two presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL.
  • The primary endpoint was overall survival (OS), and the secondary endpoints were progression-free survival (PFS) and objective response rate (ORR).
  • 42 patients of the vebreltinib group and 39 patients of the chemotherapy group were included in the full analysis set.
  • The median PFS in the vebreltinib group and chemotherapy group was 1.87 months (95% CI, 1.41-2.76) and 1.05 months (95% CI, 0.95-1.77), respectively.

Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching

Retrieved on: 
Monday, June 3, 2024

Inocras, a leading AI-driven whole genome testing company, and Massive Bio, a cutting-edge AI-driven clinical trial matching platform provider, have joined forces to set a new standard for cancer patient care.

Key Points: 
  • Inocras, a leading AI-driven whole genome testing company, and Massive Bio, a cutting-edge AI-driven clinical trial matching platform provider, have joined forces to set a new standard for cancer patient care.
  • This strategic collaboration leverages Inocras's expertise in whole genome sequencing (WGS) and bioinformatics alongside Massive Bio's advanced AI technology for clinical trial matching, with the shared mission of enhancing personalized care for cancer patients.
  • Given the historically burdensome task of finding suitable clinical trials for cancer patients, partnering with Massive Bio is paramount.
  • Utilizing AI to enhance equitable access and precision targeting for clinical trial matching, drug matching, and drug development, Massive Bio is committed to breaking down barriers in clinical trial enrollment, fostering value-based oncology decisions, and facilitating data-driven cancer treatment.

Steelworkers head into fourth week of strike, call on SNOLAB to bargain fair contract

Retrieved on: 
Tuesday, May 28, 2024

SNOLAB has instead opted to use scab labour to perform the jobs of the striking USW members, undermining the collective bargaining process.

Key Points: 
  • SNOLAB has instead opted to use scab labour to perform the jobs of the striking USW members, undermining the collective bargaining process.
  • “Some of our members haven’t seen a wage increase from SNOLAB in three years.
  • One thing is clear: the USW members enjoy widespread support in their battle for a fair contract that meets the realities of living in 2024.
  • SNOLAB needs to get back to the bargaining table, negotiate a fair contract and stop using scab labour.

Compensation Advisory Partners Promotes Shaun Bisman and Bonnie Schindler to Partner

Retrieved on: 
Wednesday, May 22, 2024

Compensation Advisory Partners (CAP), a national executive compensation consulting firm, today announced that Shaun Bisman and Bonnie Schindler have been promoted to Partner.

Key Points: 
  • Compensation Advisory Partners (CAP), a national executive compensation consulting firm, today announced that Shaun Bisman and Bonnie Schindler have been promoted to Partner.
  • “Both Bonnie and Shaun have consistently demonstrated their commitment to CAP and their clients throughout their careers and we are pleased to recognize their accomplishments with these promotions,” said Kelly Malafis, Founding Partner, Compensation Advisory Partners.
  • Throughout his more than 15-year career, Mr. Bisman has consulted with management and compensation committees to help them make informed compensation program decisions and understand their implications.
  • Ms. Schindler leads CAP’s Chicago office and has expertise in financial services, private and family-owned companies, and the communication of compensation programs.

Stellantis Sponsors Mopar Career Automotive Program Scholarships for Indigenous Students

Retrieved on: 
Tuesday, May 14, 2024

Worth up to $20,000 (USD) each, the scholarships will reimburse awarded students for purchasing the necessary tools and for two years of tuition at a participating Mopar Career Automotive Program (CAP) college or trade school.

Key Points: 
  • Worth up to $20,000 (USD) each, the scholarships will reimburse awarded students for purchasing the necessary tools and for two years of tuition at a participating Mopar Career Automotive Program (CAP) college or trade school.
  • "Our Indigenous employees and the Indigenous Cultural Opportunity Network business resource group are strong role models promoting the vast opportunities available to the talented Indigenous students who will benefit from these scholarships."
  • The Jeep brand is a proud supporter of many Stellantis business resource groups, including Indigenous Cultural Opportunity Network (ICON).
  • "Helping to secure funding for these Mopar CAP scholarships for Indigenous students gives the Jeep brand an opportunity to invest in the future of students who want to follow a career in automotive."

DATA-DRIVEN INSIGHTS CRITICAL TO EV CHARGING DECISIONS

Retrieved on: 
Tuesday, May 14, 2024

ALEXANDRIA, Va., May 14, 2024 /PRNewswire/ -- Electric vehicle (EV) charging station utilization tends to be highest in densely populated, higher-income areas near parks and shopping amenities, according to data from more than 1,000 DC fast chargers analyzed by the Transportation Energy Institute's (TEI) new Charging Analytics Program (CAP).

Key Points: 
  • CAP subscribers will get insights on when, where and how EV chargers are being used based on the latest aggregated data.
  • Reports and interactive maps will help site hosts fine-tune their strategy for successfully entering the EV charging market.
  • "CAP layers EV market and charger deployment data with insights from EV infrastructure and retail business experts to provide actionable intelligence for charger deployment."
  • CAP is powered by Caret®, CSE's proprietary forecasting, planning and program management software suite for EVs and EV charging.

Wider Risks of Online Piracy in Singapore Continue to be Felt as Singapore Courts Order More Sites Blocked

Retrieved on: 
Monday, April 15, 2024

CAP welcomes the latest round of blocking ordered by the Singapore High Court and notes the real and clear dangers presented to consumers by such sites.

Key Points: 
  • CAP welcomes the latest round of blocking ordered by the Singapore High Court and notes the real and clear dangers presented to consumers by such sites.
  • SINGAPORE, Apr 15, 2024 - (ACN Newswire) - The Asia Video Industry Association's Coalition Against Piracy (CAP) welcomes the Singapore High Court's latest order to block another 26 illegal streaming sites and more than 100 associated domains responsible for the distribution of illegally streamed content in Singapore.
  • The order is also part of a comprehensive campaign by CAP and its members against online piracy in the region.
  • Furthermore, there was a 3.5 times greater chance of consumers being scammed when visiting these sites compared to when visiting mainstream sites(1)," added Cheetham.

Clean Air Partners Urges Region to Fight Hidden Backyard Pollution Hazards

Retrieved on: 
Monday, May 6, 2024

As part of this year’s campaign, Clean Air Partners is hosting a series of events at Baltimore-Washington area hardware stores to educate locals on how to fight hidden backyard pollution hazards.

Key Points: 
  • As part of this year’s campaign, Clean Air Partners is hosting a series of events at Baltimore-Washington area hardware stores to educate locals on how to fight hidden backyard pollution hazards.
  • For more information and resources for Air Quality Awareness week, including the Clean Air Partners Air Quality app, visit cleanairpartners.net.
  • Clean Air Partners is a public-private partnership educating the greater metropolitan Baltimore-Washington region about health risks associated with poor air quality and the impacts everyday actions have on the environment.
  • Since 1997, Clean Air Partners has been dedicated to empowering individuals and organizations to take simple actions to reduce air pollution, protect public health, and improve air quality.

GC Genome to Present New Clinical Data on Colorectal Cancer Detection at the ASCO Annual Meeting 2024

Retrieved on: 
Tuesday, May 7, 2024

YONGIN, South Korea, May 7, 2024 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, today announced that it will present the new clinical data of its AI-based liquid biopsy platform on colorectal cancer detection at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.

Key Points: 
  • YONGIN, South Korea, May 7, 2024 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, today announced that it will present the new clinical data of its AI-based liquid biopsy platform on colorectal cancer detection at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
  • Title: Non-invasive colorectal cancer detection using multimodal deep learning ensemble classifier.
  • Established in 2013 as a GC company, GC Genome operates a CAP-accredited laboratory and places the utmost emphasis on R&D.
  • With steadfast partnerships established worldwide, GC Genome has shown impressive growth momentum, continually expanding our testing capacities.